Placebo to cannabidiol

DRUG4 trials

Sponsors

Hospital Universitario 12 De Octubre, Regionshospital Nordjylland

Conditions

Prostate canceralcohol dependence

Phase 2

Phase II, Placebo-controlled trial of Cannabidiol for the treatment of alcohol dependence (PLACONCANALDE)

WithdrawnCTIS2023-504439-42-00

Hospital Universitario 12 De Octubrealcohol dependence

Target: 118Updated: 2024-12-16

Efficacy and safety of cannabidiol for pain relief of patients with end-stage metastatic castration resistant prostate cancer - a randomised double-blinded placebo-controlled phase II trial (ProCan)

Not yet recruitingCTIS2024-513951-33-00

Regionshospital NordjyllandProstate cancer

Target: 58Updated: 2025-04-29

Phase II, Placebo-controlled trial of Cannabidiol for the treatment of alcohol dependence (PLACONCANALDE)

WithdrawnCTIS2023-504439-42-01

Hospital Universitario 12 De Octubrealcohol dependence

Target: 118Updated: 2025-09-30

Phase II, Placebo-controlled trial of Cannabidiol for the treatment of alcohol dependence (PLACONCANALDE)

Not yet recruitingCTIS2023-504439-42-03

Hospital Universitario 12 De Octubrealcohol dependence

Target: 118Updated: 2026-06-08